Thomas Gresalfi, in Archdale, NC - Psychiatry & Neurology

Thomas Gresalfi, is a Psychiatry & Neurology - Psychiatry physician based in Archdale, North Carolina. Thomas Gresalfi is licensed to practice in North Carolina (license number 29745) and his current practice location is 205 Balfour Dr, Archdale, North Carolina. He can be reached at his office (for appointments etc.) via phone at (336) 431-0700.

NPI number for Thomas Gresalfi is 1245261163 and his current mailing address is 284 Executive Park Dr Ste 100, Concord, North Carolina. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1245261163.

Contact Information

	Thomas Gresalfi,
	205 Balfour Dr, Archdale, NC 27203-6760
	(336) 431-0700
	(336) 431-0762

Physician's Profile

Full Name	Thomas Gresalfi
Gender	Male
Speciality	Psychiatry & Neurology - Psychiatry
Location	205 Balfour Dr, Archdale, North Carolina
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1245261163
Provider Enumeration Date: 07/06/2006
Last Update Date: 05/26/2017

Medical Identifiers

Medical identifiers for Thomas Gresalfi such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1245261163	NPI	-	NPPES
8937211	Medicaid	NC
204004C	Other	NC	MEDICARE-RELATED NUMBER OF LONG-STANDING DURATION

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2084P0800X	Psychiatry & Neurology - Psychiatry	29745 (North Carolina)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Thomas Gresalfi is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Thomas Gresalfi, 284 Executive Park Dr Ste 100, Concord, NC 28025-1833 Ph: (704) 939-1100	Thomas Gresalfi, 205 Balfour Dr, Archdale, NC 27203-6760 Ph: (336) 431-0700

News Archive

West Australians above the age of 69 at risk of sun-related skin cancer death

A new Western Australian study has revealed the mortality from non-melanoma skin cancer (NMSC), commonly considered less dangerous than melanoma, is affecting older Australians at a worrying rate.

Geroscience takes center stage in Journal of the American Medical Association

Geroscience-the burgeoning research field that focuses on the genetic, molecular, and cellular mechanisms that make aging a major risk factor for most chronic diseases as we age-takes center stage in the Journal of the American Medical Association, the world's most widely circulated medical journal.

Early intervention with GLP-1 analogues may delay onset of type 2 diabetes

GLP-1 is a hormone that regulates glucose levels in the body by stimulating the secretion of insulin, and GLP-1 also inhibits appetite. "We have found that GLP-1 is reduced by up to 25% among people with pre-diabetes and up to 20% among obese people compared to normal weight people.

Gene expression levels may reveal stage of Huntington's disease

A survey of the genome of patients with Huntington's Disease (HD) has identified potential markers of the progression of this devastating neurological disorder.

Cancer signatures uncovered

A new systematic analysis of the relationship between the neoplastic and developmental transcriptome provides an outline of trends in cancer gene expression. The research, published recently in BioMed Central's open access journal Genome Biology, describes how cancers can be divided into three groups distinguished by disparate developmental signatures.

Thomas Gresalfi, - Psychiatry & Neurology in Archdale, NC